key: cord-0809276-jqri6blo authors: Naserghandi, Alvand; Saffarpour, Reyhaneh; Allameh, Seyed Farshad title: Exploring the causes of mild COVID-19 involvement in pediatric patients date: 2020-08-11 journal: New Microbes New Infect DOI: 10.1016/j.nmni.2020.100741 sha: a9a5fca8baf33cb852359b13553a1ab7a5065515 doc_id: 809276 cord_uid: jqri6blo Abstract In December 2019, emergence of a novel coronavirus, which rapidly turned into a pandemic, posed a public health threat of global concern that has had a huge impact on the health of millions of people around the world. Existing evidence indicates relatively low incidence and mild severity of COVID-19 in children as compared to adults. Although the precise underlying reasons for such disparity remain obscure. The article provides general information about the COVID-19 and epidemiological data of the disease in children and their clinical manifestations and multisystem inflammatory syndrome in children (MIS-C). The main aim of this article is to exploring the reasons given for the mildness of the disease in pediatric patients. Several theories related to immunosenescence, vaccination and trained immunity, coinfection, ACE-2 maturation and expression, viral exposure, overall health and smoking have been proposed so far in recent literature. However, due to the newfound of this virus and lack of information about it, these reasons are not conclusive, but these points are considered as possible reasons for the low prevalence and mildness of the disease in pediatric patients. • The rapid global spread of COVID-19 has become a major 28 health issue world-wide while children show milder 29 severity and lower incidence than adults. • Another concern regarding the epidemic of the SARS-CoV- Organization (WHO) (2, 3).In the early reports on COVID-19, 60 children were rarely involved and showed a milder disease and 61 a better prognosis than adults. In the first report of 27 patients 62 which was subsequently revised to 41 (4) In conclusion, differences in immune system, degrees of ACE- COVID-19) outbreak: a 404 review of the current literature Clinical 415 features of patients infected with 2019 novel coronavirus in Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 419 novel coronavirus pneumonia in Wuhan, China: a descriptive study Systematic review of COVID-19 in children 434 show milder cases and a better prognosis than adults COVID-19 infection in children Lessons unfolding from 440 pediatric cases of COVID-19 disease caused by SARS-CoV-2 441 infection Clinical 443 characteristics of novel coronavirus disease COVID-19: Insights from simultaneous familial Kawasaki Disease 461 cases Toxic shock-like 463 syndrome and COVID-19: A case report of multisystem 464 inflammatory syndrome in children (MIS-C). The American Journal 465 of Emergency Medicine Multisystem Inflammatory Syndrome with Features of Atypical 468 Kawasaki Disease during COVID-19 Pandemic New spectrum of COVID-474 the transmission chain. Lancet Infect Dis. 2020. 489 29. Pawelec G. Age and immunity: What is 490 "immunosenescence Immunosenescence and Inflamm-Aging As Two Sides of 493 the Same Coin: Friends or Foes? Front Immunol The pathogenesis and treatment of the 495 `Cytokine Storm' in COVID-19 On the alert for cytokine storm: Immunopathology 499 in COVID-19. Arthritis & Rheumatology. 2020 COVID-19: consider cytokine storm syndromes and 502 Reduction and functional exhaustion of T cells in patients with 515 coronavirus disease 2019 (COVID-19) Functional exhaustion of antiviral lymphocytes in COVID-19 The mystery behind childhood sparing 520 by COVID-19 SARS-CoV-2 525 infection in children: Transmission dynamics and clinical 526 characteristics Smoking decreases the response of human 597 lung macrophages to double-stranded RNA by reducing TLR3 598 expression ACE2 Receptor Expression and Severe Acute Respiratory Syndrome 601 Nicotine and the renin-angiotensin system Bulk and single-cell transcriptomics identify tobacco-608 use disparity in lung gene expression of ACE2, the receptor of 2019-609 nCov Susceptibility 611 Analysis of COVID-19 in Smokers Based on ACE2